M S Pharma And Surgical

The Veenat 400 mg Tablet is an anti-cancer prescription medication with the active ingredient Imatinib mesylate. It is a targeted therapy belonging to the class of drugs known as protein-tyrosine kinase inhibitors. Key Details

• Active Ingredient: Imatinib mesylate (400 mg)
• Manufacturer: Commonly manufactured by Natco Pharma Ltd. and others
• Mechanism of Action: It works by blocking the action of an abnormal protein, the bcr-abl tyrosine kinase, which signals cancer cells to grow and multiply uncontrollably. By inhibiting this specific protein, the medication slows or stops the spread of cancer cells while minimizing damage to healthy cells. 

The Neukine 150 Mcg Injection is a medication containing Filgrastim, which is a human granulocyte colony-stimulating factor (G-CSF). It works by stimulating the bone marrow to produce white blood cells (specifically neutrophils), which are crucial for fighting infections. Key Details

• Active Ingredient: Filgrastim (150 mcg).
• Manufacturer: Intas Pharmaceuticals Ltd..
• Form: Solution for injection (liquid form).
• Administration: It is administered by a qualified healthcare professional, either under the skin (subcutaneous) or into a vein (intravenous infusion); it should not be self-administered. 

The Mycofit S Tablet is an immunosuppressant medication containing Mycophenolate sodium (or Mycophenolic acid, depending on the specific formulation) as its active ingredient. It is primarily used with other medicines to prevent the body from rejecting a transplanted organ. Key Information

• Active Ingredient: Mycophenolate sodium (which converts to mycophenolic acid in the body).
• Therapeutic Class: Immunosuppressant.
• Mechanism of Action: It works by weakening the body's immune system, specifically by inhibiting the growth and proliferation of T and B lymphocytes (white blood cells that attack foreign invaders, including transplanted organs). This action helps the body accept the new organ.
• Uses: Prevention of organ rejection in patients who have received a kidney, heart, or liver transplant. It is typically part of a combination therapy with other immunosuppressive drugs.
• Manufacturer: Intas Pharmaceuticals Ltd..
• Dosage Forms: It is available in various strengths, such as 180 mg and 360 mg tablets. 

Pegfilgrastim 6 mg injection is a prescription medication in the class of drugs known as granulocyte colony-stimulating factors (G-CSF). It is primarily used to prevent serious infections (febrile neutropenia) in patients undergoing certain types of chemotherapy for non-myeloid cancers by stimulating the bone marrow to produce more infection-fighting white blood cells (neutrophils). Key Details

• Active Ingredient: Pegfilgrastim 6 mg.
• Formulation: It typically comes as a clear, colorless, preservative-free solution in a single-dose pre-filled syringe (0.6 mL volume) for manual injection. Some brands also offer an on-body injector device.
• Mechanism of Action: Pegfilgrastim is a long-acting, man-made protein that mimics the natural G-CSF protein in the body. It binds to receptors on blood-forming cells in the bone marrow, prompting them to create, mature, and release more neutrophils into the bloodstream.
• Administration: It is given as a subcutaneous injection (under the skin), usually in the thigh, abdomen, or the back of the upper arm. It is typically administered once per chemotherapy cycle, at least 24 hours after the last dose of chemotherapy. 

Zoldonat 4 mg Injection contains the active ingredient Zoledronic acid (a bisphosphonate) and is used primarily to strengthen bones and regulate calcium levels in the blood. It is a prescription medication administered intravenously by a healthcare professional. Key Information

• Active Ingredient: Zoledronic acid 4 mg.
• Mechanism of Action: It works by suppressing the activity of osteoclasts, which are cells responsible for breaking down bone tissue. This process helps to increase bone density, minimize the risk of fractures, and decrease the amount of calcium released from bones into the bloodstream.
• Administration: The injection is given as an intravenous infusion (a drip into a vein) over at least 15 minutes by a doctor or nurse in a clinical setting. It should not be self-administered. 

Abirapro 250 mg tablets contain Abiraterone acetate (250 mg), which is a prescription anti-cancer medication used to treat advanced prostate cancer in adult men. It is a hormonal treatment, not a traditional chemotherapy drug. Key Information

• Active Ingredient: Abiraterone acetate 250 mg.
• Manufacturer: Glenmark Pharmaceuticals Ltd.
• Mechanism of Action: Abiraterone works by inhibiting the CYP17 enzyme, which is responsible for the production of male hormones (androgens) like testosterone in the testes, adrenal glands, and prostate tumor tissue. By decreasing these hormone levels, it slows down the growth and spread of cancer cells.
• Uses: It is primarily used to treat prostate cancer that has spread to other parts of the body (metastatic prostate cancer). It may be used for castration-resistant prostate cancer (cancer that has stopped responding to other hormone therapies) or high-risk castration-sensitive prostate cancer (when used with other treatments that lower testosterone).
• Administration: The tablets must be swallowed whole with water on an empty stomach (at least one hour before or two hours after a meal) to ensure proper absorption and avoid side effects.
• Combination Therapy: It is usually prescribed in combination with a steroid medication such as prednisone or prednisolone to manage potential side effects like high blood pressure, fluid retention, and low potassium levels. 

Thalix 50mg Capsules contain Thalidomide, which is an immunomodulatory agent used primarily to treat specific conditions like multiple myeloma (a type of blood cancer) and erythema nodosum leprosum (ENL), an inflammatory complication of leprosy. Key Information

• Active Ingredient: Thalidomide 50mg.
• Mechanism of Action: It modulates the body's immune system, has anti-inflammatory properties, and inhibits angiogenesis (the formation of new blood vessels needed for cancer growth).
• Administration: It is an oral capsule that should be swallowed whole with water, typically once daily, often at bedtime to help manage sleepiness. It is usually recommended to take it on an empty stomach or at least one hour after food. 

Anastrozole is an oral prescription medication in the class of drugs known as aromatase inhibitors. It is primarily used to treat hormone receptor-positive breast cancer in women who have gone through menopause. Key Description Points

• Mechanism of Action: Anastrozole blocks the enzyme aromatase, reducing estrogen levels to slow or stop the growth of estrogen-dependent breast cancer cells.
• Uses: It is used as adjuvant treatment for early-stage hormone receptor-positive breast cancer, as first-line treatment for locally advanced or metastatic hormone receptor-positive breast cancer, and for advanced breast cancer that has progressed after tamoxifen treatment. It may also be used preventatively for women at high risk.
• Dosage and Administration: The typical dosage is a 1 mg tablet taken by mouth once daily, usually long-term.
• Target Population: It is indicated for postmenopausal women and should not be used by pregnant or breastfeeding women.
• Common Side Effects: Side effects may include hot flashes, joint pain, fatigue, nausea, headache, and rash.
• Serious Considerations: Long-term use can increase the risk of osteoporosis and fractures due to decreased bone density. It may also increase the risk of heart problems and high cholesterol in women with certain conditions.